ArticleTherapeutic advances in hematology2021

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.

Alexandros Rampotas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.